EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prioritizing clinical utility to use allostatic load as a biomarker of the consequences of stress

Zoe L Walts, Melissa Rosenkranz, Anne D Letocha, Amy Cochran, Amy Trentham-Dietz, Martha J Shrubsole, Shaneda Warren Andersen

GeroScience · 07.08.2026

DOI: 10.1007/s11357-026-02451-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift GeroScience, online erschienen am 07.08.2026. Verfasst von Zoe L Walts und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Population Health Sciences, School of Medicine and Public Health, University of Wisconsin-Madison, 610 Walnut St, WARF Office Building,…. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Division of Cancer Epidemiology and Genetics, National Cancer Institute, University of Wisconsin Carbone Cancer Center, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Allostatic load measures the physiological consequences of stress and is associated with disease outcomes. Clinical use of allostatic load is limited, in part, because its calculation requires biomarkers not routinely measured in clinical care. Presently, we evaluated associations between high allostatic load and depression as co-occurring consequences of stress among a cohort representing population subgroups largely excluded from existing literature. We emphasize clinical implementation potential by employing both an established and a recent consensus streamlined allostatic load score. Data arise from a nested case–control study within the Southern Community Cohort Study ( N = 982); 72% self-identified as Black, 61% reported income < $15,000. At baseline, participants completed surveys and provided blood samples analyzed for immune, metabolic, and cardiovascular biomarkers. Biomarkers exceeding clinical cutoffs were summed; counts above median indicated high allostatic load. Established and streamlined scores include 10 (albumin, C-reactive protein, estimated creatinine clearance, BMI, HbA1C, homocysteine, systolic and diastolic blood pressure, total cholesterol, triglycerides) and a subset of 5 biomarkers, respectively. Logistic regression models assessed cross-sectional associations between depression and allostatic load at study entry (odds ratios [OR], 95% confidence intervals [CI]). Established and streamlined scores demonstrated 88% agreement in identifying high allostatic load. Depression was associated with high allostatic load using both scores (established: OR: 1.37, 95%CI: 1.02–1.86; streamlined: OR: 1.39, 95%CI: 1.03–1.87). Associations remained in sex, race, and CRC-status stratified analyses. Robust associations were observed between depression, as a proxy measure of stress, with high allostatic load, supporting its validity as a clinically actionable biomarker of physiological and psychological dysregulation within an understudied population. Implementing the streamlined score may increase feasibility of allostatic load as a clinical indicator of stress.

Schlagwörter

Stichwörter der Autor:innen

Allostatic loadCross-sectional studyDepressionSocial determinants of health

Autor:innen und Institutionen

  • Department of Population Health Sciences, School of Medicine and Public Health, University of Wisconsin-Madison, 610 Walnut St, WARF Office Building, Suite 1007B, Madison, WI, USA.
  • School of Medicine and Public Health, University of Wisconsin Carbone Cancer Center, University of Wisconsin-Madison, Madison, WI, USA.
  • Department of Psychiatry, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA.
  • Center for Health Minds, College of Letters & Science, University of Wisconsin-Madison, Madison, WI, 53726, USA.
  • School of Nursing, University of Wisconsin-Madison, Madison, WI, USA.
  • Department of Mathematics, University of Wisconsin-Madison, Madison, WI, USA.

Förderung

  • Division of Cancer Epidemiology and Genetics, National Cancer Institute
  • University of Wisconsin Carbone Cancer Center
  • NCATS NIH HHS
  • National Center for Advancing Translational Sciences

Zitieren

APA

Walts, Z. L., Rosenkranz, M., Letocha, A. D., Cochran, A., Trentham-Dietz, A., Shrubsole, M. J., & Andersen, S. W. (2026). Prioritizing clinical utility to use allostatic load as a biomarker of the consequences of stress. GeroScience. https://doi.org/10.1007/s11357-026-02451-0

Vancouver

Walts ZL, Rosenkranz M, Letocha AD, Cochran A, Trentham-Dietz A, Shrubsole MJ, et al. Prioritizing clinical utility to use allostatic load as a biomarker of the consequences of stress. GeroScience. 2026. doi:10.1007/s11357-026-02451-0

BibTeX
@article{Walts2026,
  author = {Walts, Zoe L and Rosenkranz, Melissa and Letocha, Anne D and Cochran, Amy and Trentham-Dietz, Amy and Shrubsole, Martha J and Andersen, Shaneda Warren},
  title = {Prioritizing clinical utility to use allostatic load as a biomarker of the consequences of stress},
  journal = {GeroScience},
  year = {2026},
  doi = {10.1007/s11357-026-02451-0}
}
Kostenlos starten →